Travere therapeutics CEO Eric M. Dube sells $273,455 in stock By Investing.com

Published on 13 Feb 2025 on Investing.com

Eric M. Dube, CEO of Travere Therapeutics, Inc. (NASDAQ:TVTX), recently sold 11,375 shares of the...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this articl...

Insider Monkey · via Yahoo Finance 14 Feb 2025

SAN DIEGO—Inrig Jula, Chief Medical (TASE:PMCN) Officer at Travere Therapeutics, Inc. (NASDAQ:TVT...

Investing.com 13 Feb 2025

Eric M. Dube, CEO of Travere Therapeutics, Inc. (NASDAQ:TVTX), recently sold 11,375 shares of the...

Investing.com 13 Feb 2025

SAN DIEGO—Peter Heerma, Chief Commercial Officer of Travere Therapeutics, Inc. (NASDAQ:TVTX),...

Investing.com 13 Feb 2025

We recently published a list of These 10 Companies Led Tuesday’s Charge. In this article, we are...

Insider Monkey · via Yahoo Finance 12 Feb 2025

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX) rose 7% following the company's announcement o...

Investing.com 11 Feb 2025

Net Product Sales: $61 million for Q3 2024, up from $33.9 million in Q3 2023, an increase of...

GuruFocus.com · via Yahoo Finance 1 Nov 2024

Travere Therapeutics Inc (NASDAQ:TVTX) is set to release its Q3 2024 earnings on October 31, 2024...

GuruFocus.com · via Yahoo Finance 30 Oct 2024

Overview of the Recent Transaction On September 30, 2024, State Street Corp executed a significan...

GuruFocus.com · via Yahoo Finance 19 Oct 2024

Travere Therapeutics Inc (TVTX) reports a 77% increase in net product sales, driven by FILSPARI's...

GuruFocus.com · via Yahoo Finance 9 Oct 2024